These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1601530)

  • 21. Estimating treatment means in a mixed-effect ANOVA model for bioequivalence studies.
    Hsuan FC
    Biometrics; 1993 Sep; 49(3):703-13. PubMed ID: 8241367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A semi-parametric Bayesian approach to average bioequivalence.
    Ghosh P; Rosner GL
    Stat Med; 2007 Mar; 26(6):1224-36. PubMed ID: 16832840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence and intrasubject variability.
    Liu JP
    J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
    Quiroz J; Ting N; Wei GC; Burdick RK
    Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers.
    Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA
    Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extension to the use of tolerance intervals for the assessment of individual bioequivalence.
    Esinhart JD; Chinchilli VM
    J Biopharm Stat; 1994 Mar; 4(1):39-52. PubMed ID: 8019583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of two formulations of piroxicam.
    Michotte Y; Van Klaveren HP; Detaevenier MR; Gusdorf CF; Vanhaelst
    Arzneimittelforschung; 1991 Mar; 41(3):244-6. PubMed ID: 1867660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multivariate test for population bioequivalence.
    Chervoneva I; Hyslop T; Hauck WW
    Stat Med; 2007 Mar; 26(6):1208-23. PubMed ID: 16810712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of two or more samples of quantitative data].
    Ivanković D; Tiljak MK
    Acta Med Croatica; 2006; 60 Suppl 1():37-46. PubMed ID: 16526306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar.
    Schall R
    Biometrics; 1995 Jun; 51(2):615-26. PubMed ID: 7662849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of bioequivalence].
    Aoyagi N
    Eisei Shikenjo Hokoku; 1996; (114):141-2. PubMed ID: 9037886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of parametric and nonparametric two one-sided tests procedures for assessing bioequivalence of average bioavailability.
    Liu JP; Weng CS
    J Biopharm Stat; 1993 Mar; 3(1):85-102. PubMed ID: 8485538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical aspects of comparative bioavailability trials.
    Westlake WJ
    Biometrics; 1979 Mar; 35(1):273-80. PubMed ID: 583027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative bioavailability of two tablet formulations of metoclopramide hydrochloride.
    el-Sayed YM; Niazy EM; al-Rayes S; Ismail AO; Gouda MW
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):136-9. PubMed ID: 7599911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical analysis of pharmacokinetic data with special applications to bioequivalence studies.
    Powers J; Powers T
    Ann Rech Vet; 1990; 21 Suppl 1():87S-92S. PubMed ID: 2080852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of individual and population bioequivalence.
    Chinchilli VM
    J Biopharm Stat; 1996 Mar; 6(1):1-14. PubMed ID: 8838775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An approach to select the appropriate statistical method for testing bioequivalence.
    Steyn HS; Koeleman HA; Gouws E; Ritschel WA
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):156-60. PubMed ID: 1822089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple formula for sample size calculation in equivalence studies.
    Zhang P
    J Biopharm Stat; 2003 Aug; 13(3):529-38. PubMed ID: 12921399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian modeling of multivariate average bioequivalence.
    Ghosh P; Gönen M
    Stat Med; 2008 Jun; 27(13):2402-19. PubMed ID: 18095275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.